跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 932 条关于
“PH2”
全部
932
临床试验
576
药物
222
机构
4
资讯
130
5个月前
Oral Drug N-PPG Shows Complete Prevention of Kidney Stones and Death in Rare Disease Model
去年
Gradient Denervation Technologies Expands Pulmonary Hypertension Trial and Appoints Stanton Rowe to Board
去年
Gradient's Pulmonary Artery Denervation System Receives FDA Breakthrough Designation for Pulmonary Hypertension
去年
FDA Approves Alnylam's Oxlumo as First Treatment for Ultra-Rare Kidney Disease PH1
11个月前
VCN-01 Oncolytic Virus Shows Promising Survival Benefits in Metastatic Pancreatic Cancer Trial
去年
Efgartigimod Shows Efficacy in CIDP Patients Regardless of Prior Treatment
去年
Vistagen's PH284 Nasal Spray Shows Promise in Treating Cancer Cachexia
去年
Positive Outlook for Akero Therapeutics Based on Promising Clinical Trial Developments
11个月前
Merck Faces Patent Challenge Over Keytruda Qlex as PTAB Institutes Seven Post-Grant Reviews
9个月前
argenx Discontinues Phase 3 UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease Following Futility Analysis
第 1 页,共 13 页
上一页
下一页